RGEN Repligen Corporation Stock Quote

RGEN [NASD]

Healthcare | Medical Instruments & Supplies | USA

Index	-	P/E	192.51	EPS (ttm)	1.11	Insider Own	0.60%	Shs Outstand	53.19M	Perf Week	3.49%
Market Cap	11.70B	Forward P/E	95.95	EPS next Y	2.22	Insider Trans	-19.11%	Shs Float	50.34M	Perf Month	8.36%
Income	59.90M	PEG	6.11	EPS next Q	0.42	Inst Own	84.50%	Short Float	3.08%	Perf Quarter	0.49%
Sales	366.30M	P/S	31.93	EPS this Y	155.50%	Inst Trans	2.21%	Short Ratio	3.87	Perf Half Y	25.59%
Book/sh	28.75	P/B	7.42	EPS next Y	16.45%	ROA	3.80%	Target Price	236.71	Perf Year	102.86%
Cash/sh	13.08	P/C	16.31	EPS next 5Y	31.50%	ROE	5.00%	52W Range	102.13 - 228.84	Perf YTD	11.31%
Dividend	-	P/FCF	291.71	EPS past 5Y	31.90%	ROI	4.00%	52W High	-8.06%	Beta	0.83
Dividend %	-	Quick Ratio	2.50	Sales past 5Y	34.40%	Gross Margin	57.20%	52W Low	106.01%	ATR	7.14
Employees	1128	Current Ratio	2.80	Sales Q/Q	56.30%	Oper. Margin	19.10%	RSI (14)	56.27	Volatility	2.66% 3.53%
Optionable	Yes	Debt/Eq	0.16	EPS Q/Q	420.70%	Profit Margin	16.40%	Rel Volume	0.35	Prev Close	213.30
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Feb 24 BMO	Payout	0.00%	Avg Volume	400.49K	Price	210.40
Recom	1.70	SMA20	5.12%	SMA50	2.96%	SMA200	18.32%	Volume	106,115	Change	-1.36%

Nov-10-20

Initiated

KeyBanc Capital Markets

Overweight

$241

Aug-24-20

Reiterated

H.C. Wainwright

Buy

$151 → $168

Jun-30-20

Reiterated

H.C. Wainwright

Buy

$143 → $151

May-07-20

Reiterated

H.C. Wainwright

Buy

$100 → $143

Mar-23-20

Reiterated

H.C. Wainwright

Buy

$110 → $100

Nov-15-19

Initiated

Stifel

Buy

Nov-01-19

Upgrade

First Analysis Sec

Outperform → Strong Buy

$107 → $110

Oct-15-19

Initiated

SVB Leerink

Outperform

$100

Aug-28-19

Reiterated

First Analysis Sec

Outperform

$95 → $107

Aug-23-19

Resumed

Stephens

Overweight

Jul-22-19

Upgrade

H.C. Wainwright

Neutral → Buy

$110

Dec-17-18

Upgrade

CL King

Neutral → Buy

Nov-12-18

Downgrade

CL King

Buy → Neutral

Sep-26-18

Initiated

H.C. Wainwright

Neutral

$49

Dec-08-17

Initiated

Citigroup

Buy

$45

Dec-05-17

Initiated

JP Morgan

Overweight

$42

Nov-13-17

Initiated

CL King

Buy

Oct-02-17

Upgrade

First Analysis Sec

Equal-Weight → Overweight

$47

Jul-21-17

Initiated

William Blair

Outperform

Feb-13-17

Upgrade

Piper Jaffray

Neutral → Overweight

Apr-13-21 05:27PM	Sage (SAGE), Biogen Report Positive Data on Essential Tremor Study Zacks
05:24PM	Myovant (MYOV), Pfizer Start Dosing in Relugolix Combo Study Zacks
Apr-12-21 10:53AM	Repligen: A Picks-And-Shovels Play On Biological Therapy Growth TipRanks
08:26AM	These 4 Measures Indicate That Repligen (NASDAQ:RGEN) Is Using Debt Safely Simply Wall St.
Apr-09-21 10:57AM	Merck (MRK) Keytruda Meets Endpoint in Kidney Cancer Study Zacks
09:40AM	Syndax's (SNDX) Axatilimab Gets FDA's Orphan Drug Tag for IPF Zacks
Apr-07-21 05:14PM	Is RGEN Stock A Buy or Sell? Insider Monkey
Apr-06-21 12:33PM	Exelixis' (EXEL) IND for Oncology Candidate Accepted by FDA Zacks
09:05AM	ACADIA (ACAD) Gets CRL From FDA for Nuplazid sNDA, Shares Down Zacks
Apr-05-21 01:16PM	Supernus (SUPN) Receives FDA Approval for ADHD Treatment Zacks
Apr-01-21 08:17AM	Syndax's (SNDX) Axatilimab Gets FDA's Orphan Drug Tag for GVHD Zacks
06:33AM	3 Overlooked Healthcare Stocks to Buy Right Now Motley Fool
Mar-30-21 11:43AM	Encompass Health (EHC) Opens Hospital, Boosts Texas Presence Zacks
10:06AM	Incyte (INCY) Gets EU Nod for Cholangiocarcinoma Drug Pemazyre Zacks
Mar-28-21 06:11AM	3 Disruptive Stocks to Buy and Hold for the Next Decade Motley Fool
Mar-26-21 11:30AM	Why Is Repligen (RGEN) Down 12.9% Since Last Earnings Report? Zacks
Mar-25-21 08:56AM	Is Repligen (RGEN) a Great Growth Stock? Zacks
Mar-19-21 09:17AM	Exelixis (EXEL) Inks Collaboration Deal to Test XL092 Combo in UC Zacks
Mar-17-21 07:30AM	Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum GlobeNewswire
Mar-09-21 09:31AM	Ultragenyx's (RARE) IND for mRNA Therapy, UX053 Cleared by FDA Zacks
09:11AM	ACADIA (ACAD) Falls as FDA Finds Deficiencies in Nuplazid sNDA Zacks
Mar-08-21 10:56AM	Is Repligen Corporation (RGEN) A Smart Long-Term Buy? Insider Monkey
Mar-03-21 12:40PM	Arena (ARNA) Tumbles as Mid-Stage Gastrointestinal Study Fails Zacks -6.01%
07:30AM	Repligen Corporation to Present at Barclays Global Healthcare Conference GlobeNewswire
Mar-02-21 10:02AM	Sarepta (SRPT) Q4 Loss Widens Y/Y, Revenues Beat Estimates Zacks
Mar-01-21 10:33AM	Perrigo (PRGO) Misses on Q4 Earnings, to Sell Generic Unit Zacks
Feb-25-21 11:56PM	Need To Know: Analysts Are Much More Bullish On Repligen Corporation (NASDAQ:RGEN) Revenues Simply Wall St.
Feb-24-21 04:41PM	Repligen Stock Pops After Covid Vaccines, Treatments Help Bolster 2020 Sales Investor's Business Daily
03:30PM	Repligen Corp (RGEN) Q4 2020 Earnings Call Transcript Motley Fool
07:47AM	Repligen: Q4 Earnings Insights Benzinga
07:30AM	Repligen Reports Fourth Quarter and Full Year 2020 Financial Results GlobeNewswire
06:30AM	Repligen Corp. to Host Earnings Call ACCESSWIRE
Feb-22-21 07:30AM	Repligen Corporation to Present at 10th Annual SVB Leerink Healthcare Conference GlobeNewswire
04:27AM	Here's Why I Think Repligen (NASDAQ:RGEN) Might Deserve Your Attention Today Simply Wall St.
Feb-12-21 11:16AM	Meridian Bioscience Shows Market Leadership With Jump To 91 RS Rating Investor's Business Daily
Feb-11-21 05:50PM	Repligen (RGEN) Outpaces Stock Market Gains: What You Should Know Zacks
03:00PM	Repligen to Report Fourth Quarter and Full Year 2020 Financial Results GlobeNewswire
11:05AM	Repligen (RGEN) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-08-21 07:36AM	Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines GlobeNewswire
Feb-05-21 05:50PM	Repligen (RGEN) Outpaces Stock Market Gains: What You Should Know Zacks
Feb-03-21 12:47PM	Zynex Shows Improved Relative Price Performance; Still Shy Of Benchmark Investor's Business Daily
Jan-26-21 01:42PM	Dow Jones, S&P 500 Up Slightly After Giving Up Gains; Microsoft In Buy Zones Ahead Of Earnings Investor's Business Daily -6.17%
Jan-19-21 01:13PM	Quidel Earns Composite Rating Upgrade To 97 Investor's Business Daily
Jan-15-21 05:23PM	Why This IBD Stock Of The Day Is On A Run As Covid Vaccine Demand Surges Investor's Business Daily
11:12AM	Repligen In Buy Zone Investor's Business Daily Video
Jan-14-21 03:16PM	Dow Jones Fades As Market Watches Biden's $2 Trillion Stimulus Plan; Jobless Claims Disappoint Investor's Business Daily
01:12PM	Dow Jones Up 130 Points As Stock Market Shrugs Off Trump Impeachment, Jobs Data Investor's Business Daily
Jan-09-21 08:00AM	Apple Stock, Chipotle Headline 5 Top Stocks Flashing Buy Signals Investor's Business Daily
Jan-08-21 01:50PM	Dow Jones Turns Lower On Sen. Manchin Comment While Nasdaq Leads, Hits New High Investor's Business Daily
Jan-05-21 05:14PM	Quidel Begins To Show Strength, Approaches Benchmark Investor's Business Daily
Jan-04-21 01:00PM	Repligen Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Jan-01-21 10:01AM	Why Repligen Stock Soared 107% in 2020 Motley Fool
Dec-30-20 10:24AM	P/E Ratio Insights for Repligen Benzinga
Dec-28-20 08:33AM	Monopar Therapeutics (MNPR) Jumps: Stock Rises 7.4% Zacks
Dec-24-20 03:47AM	How Much Did Repligen's (NASDAQ:RGEN) CEO Pocket Last Year? Simply Wall St.
Dec-21-20 10:16AM	Novartis (NVS) Gets CRL From the FDA for Cholesterol Drug Zacks
08:48AM	Atea Pharmaceuticals (AVIR) Jumps: Stock Rises 9.5% Zacks
08:46AM	Anika Therapeutics (ANIK) Surges: Stock Moves 6.6% Higher Zacks
08:24AM	4 Healthcare Stocks to Take Care of in 2021 to Boost Portfolio Zacks
Dec-20-20 03:14PM	Is RGEN A Good Stock To Buy Now According To Hedge Funds? Insider Monkey
Dec-18-20 11:04AM	X4 Pharmaceuticals (XFOR) Surges: Stock Moves 6.9% Higher Zacks
08:36AM	Lumos Pharma (LUMO) in Focus: Stock Moves 8.3% Higher Zacks
08:34AM	NeuroBo Pharmaceuticals (NRBO) Surges: Stock Moves 5.2% Higher Zacks
Dec-17-20 11:58AM	Cellectis (CLLS) Jumps: Stock Rises 9% Zacks
08:47AM	Genprex (GNPX) Looks Good: Stock Adds 6.5% in Session Zacks
Dec-16-20 05:17AM	Megatrends To Invest In Now: 3 Best ETF Picks Investor's Business Daily Video
Dec-15-20 11:30AM	Is Repligen (RGEN) Stock Outpacing Its Medical Peers This Year? Zacks
Dec-14-20 01:05PM	Viatris (VTRS) to Cut Jobs as Part of Restructuring Initiative Zacks
Dec-11-20 01:03PM	Gilead (GILD) to Buy MYR GmbH for EUR1.15 Billion in Cash Zacks
Dec-10-20 04:18PM	Repligen Corporation Announces Closing of Public Offering of $312.2 Million, Including Full Exercise of Underwriters Option GlobeNewswire
10:52AM	Rocket Pharmaceuticals (RCKT) Surges on Encouraging Study Data Zacks
Dec-08-20 12:20PM	EC Mergers & Acquisitions advised ARTeSYN on its Sale to Repligen PR Newswire
10:15AM	scPharmaceuticals (SCPH) Plunges on Complete Response Letter Zacks
Dec-07-20 09:41PM	Repligen Corporation Prices Public Offering of Shares of Common Stock GlobeNewswire
07:22AM	Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock GlobeNewswire
Dec-05-20 11:32AM	Why Is Repligen (RGEN) Down 6.7% Since Last Earnings Report? Zacks
Dec-04-20 08:29AM	Deere & Co, Chico's FAS, Aerpio Pharmaceuticals, TRACON Pharmaceuticals and Repligen Corp highlighted as Zacks Bull and Bear of the Day Zacks
Nov-25-20 09:27AM	Reata (RETA) Omaveloxolone Program Faces Delay on FDA Update Zacks
Nov-19-20 11:30AM	Is Repligen (RGEN) Stock Outpacing Its Medical Peers This Year? Zacks
08:00AM	Repligen CEO Tony Hunt Knows Why Success Takes Time Investor's Business Daily
Nov-16-20 09:51AM	Return On Capital Employed Overview: Repligen Benzinga
Nov-13-20 09:46AM	Zacks.com featured highlights include: BJ's Wholesale Club, Dollar General, Repligen Corp, Hologic and Parker-Hannifin Zacks
08:31AM	Repligen (RGEN) Looks Good: Stock Adds 6.1% in Session Zacks
08:15AM	Why It Might Be Time To Pay Attention To These 4 Red-Hot Health Stocks Investor's Business Daily
Nov-12-20 08:03AM	5 Top Stocks to Buy on Earnings Beat Potential Zacks +6.09%
Nov-10-20 09:40AM	Arena (ARNA) Q3 Earnings Top, Stock Down on Eczema Study Data Zacks
Nov-09-20 03:52PM	Stock Upgrades: Orasure Technologies Shows Rising Relative Strength Investor's Business Daily -5.06%
01:27PM	Was The Smart Money Right About Loading Up On Repligen Corporation (RGEN)? Insider Monkey
07:56AM	Repligen Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions Simply Wall St.
Nov-06-20 09:17AM	Why Shares of Repligen Soared in October Motley Fool
Nov-05-20 09:45AM	Repligen (RGEN) Tops Q3 Earnings and Revenue Estimates Zacks +8.02%
07:30AM	Repligen Reports Third Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance GlobeNewswire
Nov-04-20 03:25PM	Growing Novocure Sees Composite Rating Improve To 96 Investor's Business Daily
Oct-29-20 12:34PM	Repligen (RGEN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Oct-27-20 04:15PM	Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN Biosolutions and Completes Acquisition of Non-Metallic Solutions GlobeNewswire
Oct-22-20 12:33PM	Repligen (RGEN) Earnings Expected to Grow: What to Know Ahead of Q3 Release Zacks
07:30AM	Repligen to Report Third Quarter 2020 Financial Results GlobeNewswire
Oct-12-20 02:51PM	These 4 Measures Indicate That Repligen (NASDAQ:RGEN) Is Using Debt Reasonably Well Simply Wall St.
Oct-05-20 12:17PM	Repligen Moves Above Early Entry Point Investor's Business Daily Video +7.91%
Oct-01-20 06:30AM	Repligen and Navigo Proteins Announce Achievement of Key Milestone in Developing an Affinity Resin for the Purification of COVID-19 Vaccines GlobeNewswire

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company offers filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE and FlowVPE brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands; and Sartorius Stedim Biotech to create novel perfusion-enabled bioreactors. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bylund James	SVP, Global Operations & IT	Apr 06	Sale	204.25	360	73,530	6,324	Apr 08 07:55 PM
Gebski Christine	See Remarks	Mar 16	Sale	196.88	1,400	275,632	37,140	Mar 18 09:47 PM
Hunt Anthony	Chief Executive Officer	Mar 12	Sale	190.38	9,102	1,732,847	212,762	Mar 12 07:34 PM
KURIYEL RALF	Senior VP, R&D	Mar 10	Option Exercise	34.15	8,000	273,168	33,265	Mar 12 07:33 PM
KURIYEL RALF	Senior VP, R&D	Mar 10	Sale	190.44	8,000	1,523,501	25,265	Mar 12 07:33 PM
Hunt Anthony	Chief Executive Officer	Mar 04	Sale	190.19	21,900	4,165,091	221,864	Mar 08 09:51 PM
Snodgres Jon	Chief Financial Officer	Mar 04	Sale	192.47	3,545	682,295	32,363	Mar 08 09:50 PM
KURIYEL RALF	Senior VP, R&D	Mar 04	Sale	192.00	2,075	398,396	25,265	Mar 08 09:41 PM
RYAN THOMAS F JR	Director	Mar 03	Option Exercise	26.12	1,000	26,120	2,464	Mar 04 09:22 PM
RYAN THOMAS F JR	Director	Mar 03	Sale	205.00	1,000	205,000	1,464	Mar 04 09:22 PM
Snodgres Jon	Chief Financial Officer	Jan 25	Option Exercise	33.87	4,000	135,480	33,498	Jan 26 09:59 PM
Snodgres Jon	Chief Financial Officer	Jan 04	Sale	191.52	3,957	757,840	29,498	Jan 06 04:41 PM
KURIYEL RALF	Senior VP, R&D	Dec 16	Sale	186.18	435	80,988	25,654	Dec 18 04:30 PM
Hunt Anthony	Chief Executive Officer	Nov 19	Option Exercise	26.05	20,000	521,000	253,327	Nov 23 07:03 PM
Hunt Anthony	Chief Executive Officer	Nov 19	Sale	185.80	20,000	3,716,051	233,327	Nov 23 07:03 PM
RYAN THOMAS F JR	Director	Nov 11	Option Exercise	38.76	934	36,202	2,398	Nov 13 04:46 PM
RYAN THOMAS F JR	Director	Nov 11	Sale	187.73	934	175,340	1,464	Nov 13 04:46 PM
Snodgres Jon	Chief Financial Officer	Nov 10	Option Exercise	32.40	3,086	99,986	36,541	Nov 10 09:17 PM
Snodgres Jon	Chief Financial Officer	Nov 10	Sale	193.00	3,086	595,598	33,455	Nov 10 09:17 PM
Snodgres Jon	Chief Financial Officer	Nov 09	Option Exercise	59.52	1,893	112,671	33,455	Nov 10 09:17 PM
BARTHELEMY NICOLAS	Director	Nov 09	Sale	195.51	1,214	237,349	1,450	Nov 10 09:18 PM
Snodgres Jon	Chief Financial Officer	Nov 09	Sale	194.69	705	137,256	31,562	Nov 10 09:17 PM
Hunt Anthony	Chief Executive Officer	Sep 10	Option Exercise	26.05	45,351	1,181,394	278,678	Sep 14 07:43 AM
Hunt Anthony	Chief Executive Officer	Sep 10	Sale	148.20	45,351	6,721,018	233,327	Sep 14 07:43 AM
KURIYEL RALF	Senior VP, R&D	Aug 06	Option Exercise	33.87	5,000	169,350	31,089	Aug 10 05:35 PM
KURIYEL RALF	Senior VP, R&D	Aug 06	Sale	153.79	5,000	768,950	26,089	Aug 10 05:35 PM
RYAN THOMAS F JR	Director	Jul 31	Option Exercise	67.71	2,109	142,800	4,559	Aug 04 07:50 PM
RYAN THOMAS F JR	Director	Jul 31	Sale	151.90	3,095	470,129	1,464	Aug 04 07:50 PM
DAWES KAREN A	Director	Jun 18	Sale	115.20	18,705	2,154,851	100,734	Jun 22 04:42 PM
Hunt Anthony	Chief Executive Officer	May 21	Option Exercise	24.10	50,039	1,206,140	277,194	May 26 09:27 PM
Hunt Anthony	Chief Executive Officer	May 21	Sale	139.77	46,953	6,562,409	230,241	May 26 09:27 PM
DAWES KAREN A	Director	May 20	Sale	139.44	517	72,093	119,439	May 21 09:08 PM
BARTHELEMY NICOLAS	Director	May 18	Option Exercise	67.71	2,109	142,800	5,673	May 26 09:24 PM
BARTHELEMY NICOLAS	Director	May 18	Sale	142.53	3,009	428,873	2,664	May 26 09:24 PM
DAWES KAREN A	Director	May 18	Sale	137.78	1,600	220,448	119,956	May 19 08:46 PM
KURIYEL RALF	Senior VP, R&D	May 15	Sale	140.69	435	61,200	26,089	May 19 08:54 PM
Snodgres Jon	Chief Financial Officer	May 15	Sale	140.43	660	92,684	32,267	May 19 08:47 PM
KURIYEL RALF	Senior VP, R&D	May 13	Option Exercise	33.26	8,000	266,040	34,524	May 15 05:37 PM
Snodgres Jon	Chief Financial Officer	May 13	Option Exercise	30.75	12,194	374,956	48,321	May 15 05:41 PM
KURIYEL RALF	Senior VP, R&D	May 13	Sale	127.80	8,000	1,022,373	26,524	May 15 05:37 PM
Snodgres Jon	Chief Financial Officer	May 13	Sale	128.74	15,394	1,981,875	32,927	May 15 05:41 PM
BARTHELEMY NICOLAS	Director	Apr 22	Option Exercise	42.07	1,652	69,500	5,725	Apr 24 05:22 PM
BARTHELEMY NICOLAS	Director	Apr 22	Sale	109.99	2,688	295,653	3,037	Apr 24 05:22 PM
DAWES KAREN A	Director	Apr 21	Option Exercise	3.30	11,800	38,940	120,834	Apr 22 06:07 PM
DAWES KAREN A	Director	Apr 20	Option Exercise	3.30	8,200	27,060	121,234	Apr 22 06:07 PM
DAWES KAREN A	Director	Apr 20	Sale	104.57	12,200	1,275,717	109,034	Apr 22 06:07 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience